Sonic Healthcare share price hits 52-week high: is it a buy?

The Sonic Healthcare Ltd (ASX: SHL) share price has fallen lower this afternoon after reaching a new 52-week high at market open.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Ltd (ASX: SHL) share price has fallen lower this afternoon after reaching a new 52-week high at market open.

a woman

What happened to the Sonic Healthcare share price?

The Sonic Healthcare share price surged higher at the start of the day to $28.66 per share despite the S&P/ASX 200 (INDEXASX: XJO) index opening lower.

Sonic Healthcare has delivered solid returns for its investors so far this year, with the company's share price climbing 29% since the start of January to outpace the ASX 200 performance over the same period.

The Aussie healthcare sector has been a strong performer this year with many of the top-performing ASX 200 shares comprising the likes of Nanosonics Ltd (ASX: NAN) and InvoCare Limited (ASX: IVC).

Is Sonic Healthcare in the buy zone?

The medical imaging and pathology group has performed strongly so far this year, but what's the catch?

Sonic Healthcare's strong share price performance has been built on a platform of strong earnings, starting with the company's strong half-year results and upgraded full-year guidance in February.

Strong organic growth in Sonic Healthcare's laboratory markets and operations segments saw the company post first-half revenue of $2.9 billion, up 9% 1H 2018.

Sonic also reported a 7% year-on-year (YoY) increase in net profit after tax (NPAT) of $223 million and increased its interim dividend to 33 cents.

Sonic lifted full-year guidance for its earnings before interest, tax, depreciation and amortisation (EBITDA) by 8%, in comparison to EBITDA of $962 million the year prior.

Foolish takeaway

Sonic Healthcare trades at a reasonable price-to-earnings (P/E) ratio of 26.2x earnings, but I still think that's a little on the high side given the ASX 200 average of approximately 17x.

Sonic is a solid dividend stock that currently yields 3% per annum, but I think the company's August full-year results will be the real kicker for investors.

If Sonic Healthcare can post solid earnings growth and deliver on its upgraded guidance and recent acquisition, I'd expect to see the Sonic Healthcare share price push beyond the $30 barrier by the end of August.

Motley Fool contributor Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia has recommended InvoCare Limited and Sonic Healthcare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman holds her hands to her face in shock and fear with a worried expression on her face.
Healthcare Shares

Where to from here for CSL shares according to Macquarie

Is there more pain in store for CSL shareholders?

Read more »

Happy healthcare workers in a lab.
Healthcare Shares

With potential upside of more than 300%, is this ASX biotech the best buy on the ASX right now?

Investors should pay attention to this compelling company.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Healthcare Shares

Is the worst over for CSL shares after this week's sell-off?

It may be too early to completely write off the biotech stock.

Read more »

Senior woman using cpap machine to stop choking and snoring from obstructive sleep apnoea with bokeh and morning light background.
Healthcare Shares

Why are Resmed shares lagging if the business keeps compounding?

Resmed shares have had a tough time of late. But investors looking to compound returns over the long-term may want…

Read more »

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
Healthcare Shares

Why is this ASX 300 share crashing over 20% today?

It is a very red day for this healthcare stock. What's happening? Let's find out.

Read more »

Six smiling health workers pose for a selfie.
Broker Notes

3 reasons this beaten down ASX All Ords healthcare share could come roaring back

A leading analyst believes this beaten down ASX healthcare stock is well-positioned for a comeback.

Read more »

A couple sits on a sofa, each clutching their heads in horror and disbelief, while looking at a laptop screen.
Healthcare Shares

Down 59%: Will CSL shares ever regain momentum?

Here's what to expect over the next 12 months.

Read more »

A woman sits in front of a computer and does some calculations.
Healthcare Shares

Should you buy ResMed shares at their 52-week low?

This company is still growing, profitable, and exposed to a large sleep health market, but the share price has fallen…

Read more »